Luca Apruzzi

Luca Apruzzi

Auto-generated profile, based on publicly available information

Luca Apruzzi

Department of Vascular Surgery, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
AKAndrea KAHLBERG
Andrea KAHLBERG
EREnrico Rinaldi
Enrico Rinaldi
GPGabriele Piffaretti
Gabriele Piffaretti
FSFrancesco Speziale
Francesco Speziale
STSanti Trimarchi
Santi Trimarchi
ASAntonio Sarcina
Antonio Sarcina

23 June 2020 in Annals of Vascular Surgery
Verified
Journal Article
Open access
PDF file
DOMENICO BACCELLIERIDOMENICO BACCELLIERI
DOMENICO BACCELLIERI
VBVictor Bilman
Victor Bilman
LALuca Apruzzi
Luca Apruzzi
FMFabrizio Monaco
Fabrizio Monaco
ADArmando D'Angelo
Armando D'Angelo
RCRoberto Chiesa
Roberto Chiesa
• Heparin resistance is a phenomenon defined as the need for high-dose unfractionated heparin to achieve the target activated partial-thromboplastin time ratio. • This case aims to describe a Covid-19 patient with acute limb ischemia who developed heparin resistance. • Covid-19 infection is a systemic endothelial disease not limited to the lungs. • Anticoagulation cannot be managed as one-size-fits-all owing to the coexistence of several “sheds of thrombophilia” (i.e. HR, deficiency of antithrombin III).

7 May 2020 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Open access
PDF file
DOMENICO BACCELLIERIDOMENICO BACCELLIERI
DOMENICO BACCELLIERI
LALuca Apruzzi
Luca Apruzzi
VAVincenzo Ardita
Vincenzo Ardita
EREnrico Rinaldi
Enrico Rinaldi
LBLuca Bertoglio
Luca Bertoglio
RCRoberto Chiesa
Roberto Chiesa

8 September 2020 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
DBDomenico Baccellieri
Domenico Baccellieri
LALuca Apruzzi
Luca Apruzzi
VAVincenzo Ardita
Vincenzo Ardita
NFNicola Favia
Nicola Favia
CSConcetta Saracino
Concetta Saracino
RCRoberto Chiesa
Roberto Chiesa

10 September 2021 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Closed access
PDF file
LALuca Apruzzi
Luca Apruzzi
VBVictor Bilman
Victor Bilman
VAVincenzo Ardita
Vincenzo Ardita
NFNicola Favia
Nicola Favia
CSConcetta Saracino
Concetta Saracino
DOMENICO BACCELLIERIDOMENICO BACCELLIERI
DOMENICO BACCELLIERI
Objective: to compare the outcomes of mechanochemical ablation (MOCA) versus saphenopopliteal junction ligation and stripping (OS) for symptomatic small saphenous vein (SSV) insufficiency. Methods: This is a retrospective study including symptomatic SSV patients treated with MOCA using the ClariVein catheter (Merit Medical, South Jordan, Utah, USA) or OS from 2015 to 2019. Results: A total of 60 limbs (73.3% women, mean age 54.7 ± 14.4 years) were treated with MOCA and 58 limbs (63.8% women, mean age 54 ± 11.6 years) with OS. At 18 months follow-up, recurrence rates were 7.5% (4/53) for MOCA vs. 5.7% (3/52) for the OS group. MOCA group was associated with less pain at first postoperative day, and an early return to work (MOCA 3.5 ± 2.3 days vs. OS 14.2 ± 3.8 days, p < .0001). No cases of leg paresthesia/dysesthesia were observed in the MOCA group, while two patients (3.4%) presented neurological symptoms after OS treatment. Conclusion: MOCA and OS are both safe and effective techniques for symptomatic SSV insufficiency. MOCA group demonstrated to be associated with less postoperative pain and early return to work compared to OS.

1 January 2021 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
LALuca Apruzzi
Luca Apruzzi
MBmatteo bossi
matteo bossi
CBCarlotta Bugna
Carlotta Bugna
LBLuca Bertoglio
Luca Bertoglio
RCRoberto Chiesa
Roberto Chiesa